CHTR

CHTR

CHTR

Letters With This Ticker

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Keywords/Themes	Theme Commentary	Pitches	Letter
2025 Q3	Sep 30, 2025	Burke Wealth Managament The Focused Growth Strategy	-0.9%	5.3%	ASML NA, BWXT, CHTR, CRM, MU, NOW	Artificial Intelligence, Enterprise Software, Nuclear Energy, semiconductors, Trade Policy	The quarter was shaped by a pro-growth US Policy backdrop combining tariffs, manufacturing reshoring, and corporate tax reform, creating a supportive environment for domestic investment and capital spending. At the same time, AI remains the dominant structural driver within equities, influencing enterprise software, semiconductors, and power infrastructure. The portfolio reflects conviction that AI-driven productivity and capex cycles will outweigh near-term volatility tied to trade negotiations and sector-specific controversies.		View
2025 Q2	Jul 8, 2025	Right Tail Capital	-	-	BYD CN, CHTR, IAC, NSC, NSIT, SCHW, SSNC	Compounding, longterm, Patience, Quality, returnsOnCapital	The strategy centers on owning high-quality businesses with strong returns on incremental capital over multi-year horizons. Volatility is embraced as part of long-term compounding rather than a signal to trade. Patience and business fundamentals are prioritized over short-term market narratives.		View
2022 Q2	Jul 21, 2022	Kovitz Core Equity Strategy	-18.5%	-22.5%	ADI, ANET, C, CHTR, CVET, DLTR, ICE, KMX, PCAR, PWR	-			View
2025 Q2	Jul 20, 2025	Brennan Asset Management	-	-	CHTR, CODI, MTRO LN, PTSB LN, TIGO	cash flow, dividends, risk management, stability, total return	The commentary emphasizes dividend-paying companies with consistent growth and financial strength. Management views dividends as a tangible component of total return and risk mitigation. The strategy favors stability over speculative growth.		View
2024 Q1	Apr 27, 2024	Parnassus Core Equity Fund	5.5%	18.2%	AAPL, AMAT, AZO, CHTR, DE, FI, INTC, ORCL, RHO GR, SPGI	-			View
2022 Q1	Apr 22, 2022	Ironvine Capital Partners, LLC	-7.2%	-7.2%	CHTR, CMCSA, DLTR	-			View
2024 Q1	Apr 15, 2024	Oakmark Global Select Fund	8.8%	0.0%	CHTR, CNC, FI, IQV, RKT LN	-			View
2024 Q1	Apr 15, 2024	Weitz Multi Cap Equity Fund	10.4%	16.3%	CHTR, CSGP	-			View
2024 Q1	Apr 15, 2024	Weitz Partners III Opportunity Fund	9.1%	14.1%	CHTR, GS, LBRDA, META	-			View
2024 Q1	Apr 15, 2024	Weitz Large Cap Equity Fund	7.8%	13.3%	CHTR, GOOG, LBRDA	-			View
2024 Q1	Apr 12, 2024	Kovitz Core Equity Strategy	10.3%	10.3%	AON, BDX, CHTR, GIL, GOOG, JPM, KMX, META, ORCL, PCAR, PPG, SPLK, SPOT	-			View
2025 Q1	Mar 31, 2025	Burke Wealth Managament The Focused Growth Strategy	-8.1%	-8.1%	ABT, CHTR, CRM, ICE, NOW, NVDA, TDG, UNH	-			View
2025 Q4	Feb 22, 2026	City Different Investments – Multi-Cap Core	2.8%	18.1%	AMG, APG, CHTR, FLYW, GILD, GOOGL, KMX, LOPE, META, MSFT, NFLX, SBUX, SCHW, TGT, TMO	Behavioral, Diversified, long-term, multi-cap, value	Mature (Value) businesses led performance in the fourth quarter and were the strongest contributors for the full year, reflecting durable execution in companies that continued to generate healthy free cash flow and return capital.	FLYW	View
2025 Q4	Dec 31, 2025	Fortress – Fixed Income Fund	0.6%	5.5%	005930.KS, 0700.HK, 1288.HK, 1585.HK, 1878.T, 2318.HK, 392.HK, 3968.HK, 6920.T, 8035.T, 916.HK, ACN, AMAT, AXP, BABA, BBDO, BNZL.L, BRK.B, BTI, CHTR, FMC, GMEXICOB.MX, GRMN, HSY, ITUB, IX, JNJ, LOGI, MC.PA, MRK, NTES, NVO, ORLY, PDD, PHM, ROG.SW, SBS, SNA, TSM, UNH, VALE, VRTX, WKL	AI, Bonds, emerging markets, healthcare, international, technology, Trade Policy, value	Artificial intelligence remained the primary focus for investors in U.S. markets, driving strength in technology names while masking moderation in other economic areas. The AI investment boom continued to power corporate capital expenditures and supply growth, though consumer confidence readings suggest potential underlying softness that could emerge if AI investment moderates. The manager sees excellent value opportunities globally, particularly in international and emerging markets despite strong recent performance. U.S. healthcare and consumer staples have been left behind by the AI frenzy and trade at appealing valuations. Portfolio companies show attractive price/earnings ratios with meaningful long-term return potential. Recent tariff policies continued to negatively impact U.S. consumers and companies throughout the year. However, international companies have been finding new trade arrangements and growth opportunities, benefiting from shifts in global trade patterns as the new U.S. administration alters terms of international cooperation.		View
2024 Q4	Dec 31, 2024	Burke Wealth Managament The Focused Growth Strategy	2.7%	28.4%	ADBE, AMZN, CHTR, CRWD, GOOG, NVO, SNOW, UEEC	-			View
2022 Q4	Dec 1, 2023	Concentrated Compounding	0.0%	0.0%	AMZN, BRK/A, CHTR, CSU CN, EPD, FRC, GOOG, MA, RADI, TDG, V	-			View
2024 Q3	Oct 28, 2024	Parnassus Core Equity Fund	5.5%	18.2%	ADBE, AMAT, AMZN, CHTR, DHI, GOOG, ICE, INTC, MU, O, SHW, SNPS, SYK, WM	-			View
2024 Q3	Oct 28, 2024	Parnassus Growth Equity Fund	3.3%	21.0%	AAPL, ADYEN, AKAM, AMAT, ARNB, CHTR, CMG, DHR, INTU, MAR, MELI, MSCI, NVDA, PCOR, SHW	-			View
2024 Q3	Oct 28, 2024	Parnassus Value Equity Fund	7.3%	13.7%	AMZN, AXP, BIIB, BK, CBRE, CHTR, DHI, GOOG, INTC, MU, ORCL, PGR, SCHW, UNH	-			View
2025 Q3	Oct 2, 2025	LRT Capital Management	-	-0.2%	ABG, CAAP, CCI, CHE, CHTR, CIGI, CM, DRI, FN, GPI, IESC, PBR, RLI, SNEX, SSD, TD, TRV, TTC, UNH, XOM	Hedges, Long/Short, Quality, Shiller PE, small caps	LRT focuses on a systematic long/short approach anchored in high-quality companies trading amid extreme market valuations. The manager highlights elevated index multiples and the opportunity created when quality factors lag speculative leadership. Quality remains compelling as valuation discipline and downside control matter more in late-cycle conditions.		View
2025 Q3	Oct 14, 2025	Pzena Investment Management	-	-	2579 JP, BAX, CHTR, LKQ, PFE, SCS, SHEKK NA, SPB, TEP FP, UHR SW, WIZZ LN	Artificial Intelligence, cyclicals, Global Equities, small caps, value	Pzena argues that small caps trade at historic lows versus large caps and are poised for multi-year outperformance. The firm views AI-driven market dislocations as openings for active value investing, focusing on normalized earnings rather than hype. The letter emphasizes select opportunities in healthcare, industrials, and global cyclicals.	WIZZ SPB TPN BAX	View
2025 Q3	Oct 10, 2025	Oakmark Global Select Fund	3.4%	17.3%	BABA, CHTR, DSY FP	AI, Broadband, Cloud, innovation, Virtual Twin	The letter highlights selective exposure to global technology and communication firms such as Alibaba and Charter, emphasizing AI-led growth and virtual twin software as durable innovation areas. It notes temporary headwinds in broadband but long-term compounding opportunities from digital platforms and infrastructure.		View
2023 Q3	Oct 10, 2023	Oakmark Global Fund	7.5%	0.0%	0R0K LN, BC, CHTR, GOOG, ORCL, SJPETLD LN	-			View
2025 Q3	Oct 1, 2025	Eagle Point Capital LLC	-	-	BTI, CHTR, LULU	CLO, credit, floating rate, Refinancing, Yield	The manager reinforces the primacy of low absolute valuations and high free cash flow yields. Paying a low price reduces the risk of permanent capital loss and improves asymmetry. Mean reversion in growth and profitability underpins the value thesis.	BTI LN	View
2025 Q4	Jan 29, 2026	Weitz Large Cap Equity Fund	0.6%	-0.2%	ADI, CHTR, CSGP, DHR, EFX, GOOGL, IDXX, IEX, IT, KMX, META, ORCL, TMO	AI, Biotechnology, Concentration, healthcare, large cap, Process Enhancement, stock selection, value	The artificial intelligence infrastructure trade took a breather after a red-hot summer. Google's Gemini AI surpassed expectations with performance moving to the front of the pack according to respected industry benchmarks, helping Alphabet solidify its spot as an AI leader.		View
2025 Q4	Jan 29, 2026	Weitz Multi Cap Equity Fund	-1.5%	3.2%	ACN, BRK-B, CDW, CHTR, CMCSA, CSGP, DHR, GOOGL, HEI, IDXX, IEX, IT, KMX, LBRDA, LH, LKQ, META, PRM, SIRI, TECH	healthcare, multi-cap, technology, Telecom, underperformance, value	Google's Gemini AI surpassed expectations with latest release, moving to front of pack among frontier models according to industry benchmarks. Investors questioning value of Gartner's research offerings in rapidly evolving GenAI landscape. Heightened competition continues weighing on broadband investments including Liberty Broadband and Charter Communications. Charter's capital investment cycle beginning to ease, expected to improve free cash flow and support share repurchases at depressed prices. CarMax faces challenging environment with constrained availability and affordability of late model used vehicles. Online competitor Carvana taking share while CarMax's omni-channel investments have yet to deliver improvements, leading to strategic changes and CEO departure.	CHTR KMX PRM	View
2025 Q4	Jan 29, 2026	Weitz Partners III Opportunity Fund	0.7%	3.2%	AMZN, AON, BRK-A, CHTR, DHR, EEFT, GOOGL, GPN, IEX, KMX, LBRDA, LH, MA, META, MSFT, ROP, SIRI, TECH, TMO, V	AI, Biotechnology, contrarian, healthcare, Long/Short, technology, value	The fund owned several companies deemed AI Winners including Alphabet, Microsoft, Amazon and Meta Platforms, averaging roughly 16% of Fund assets in 2025. Google's latest Gemini AI release surpassed expectations with benchmarks showing performance moved to the front of the pack. The fund's deep value stocks averaging roughly 16% of portfolio assets had a disproportionately negative impact on returns in 2025. As value-oriented investors, the managers are comfortable taking contrarian positions but must be clear-eyed about how companies' prospects change. The portfolio's life sciences investments representing roughly 18% of average assets experienced a lost year in 2025. The industry began with pressure on research budgets and heightened scrutiny of healthcare apparatus, reorienting around a new normal before organic growth pickup spurred a rally.	BRK.B PRM CHTR KMX GOOGL	View
2025 Q4	Jan 29, 2026	FPA Crescent Fund	3.1%	17.7%	ADI, AMZN, AVTR, BDX, C, CHTR, CMCSA, CRM, GOOGL, HEIA.AS, IFF, JEF, KMX, META, MSFT, NOW, NTDOY, ORCL, SAF.PA, SAP, SNOW, TEL, WDAY	AI, global, healthcare, Quality, small caps, technology, value	The fund emphasizes being value aware, focusing on cases where both quality and value intersect. They avoid speculative areas where reward for taking risks is insufficient relative to potential returns. The strategy has generated equity-like returns while placing equal importance on capital preservation and appreciation over 30 years. The fund is actively investing in small to mid-cap global securities, believing the investment community is casting its gaze away from these market constituents that offer asymmetric risk-reward for those willing to look forward three to five years. Recent purchases demonstrate their commitment to this thesis. The fund discusses AI extensively through Microsoft's transformation and growth prospects. They analyze how AI/cloud developments transformed Microsoft's business model and examine the massive revenue growth required for current AI valuations to make sense, questioning whether Microsoft can add revenue equivalent to multiple major software companies combined.	MSFT	View
2025 Q4	Jan 26, 2026	Harris Associates Concentrated Strategy	8.4%	14.4%	CHTR, EFX, FCNCA, GOOGL, LBRDK, PAYC, TRGP, WBD	AI, Banking, Buybacks, energy, Media, Midstream, technology, value	Warner Bros Discovery was a major contributor as multiple parties submitted acquisition offers, with Netflix acquiring the Streaming and Studios business while Global Networks spins to shareholders. Paramount Skydance made a $30 per share offer for the entire company, representing significant value unlocking opportunities in the media sector. Alphabet delivered impressive earnings with strong Cloud segment performance driven by accelerating demand for AI compute. The manager sees potential for the company's AI leadership to drive further upside across the portfolio and views Alphabet as undervalued on a sum-of-the-parts basis. First Citizens Bancshares was a contributor with solid results exceeding consensus expectations. Loans and deposits grew healthily while management continues steady share repurchases. The manager believes it's a high-quality regional bank with strong management that can unlock sustained long-term value. Targa Resources was initiated as a new position, representing a leading midstream natural gas and NGL company controlling 90% of fractionation capacity at Mont Belvieu. The company generates approximately 90% of earnings through multi-year fee-based arrangements, providing protection against oversupply with meaningful cost advantages and barriers to entry.		View
2025 Q4	Jan 23, 2026	Alluvium Global Fund	-1.1%	-0.1%	005930.KS, AN, BABA, CHTR, DKS, GOOGL, GPI, HCA, HRB, LBRDA, LNR.TO, LYB, MCK, RHI, RYAAY, THO, UMG.AS, V	AI, Airlines, global, healthcare, technology, underperformance, value	The fund discusses the rapid adoption of AI technologies, particularly Alphabet's Gemini AI which gained 650 million monthly active users in six months. Questions remain about quantifying efficiency gains and monetary benefits versus the immense capital outlays by providers. Ryanair represents the fund's largest position at 9.4%, benefiting from earlier aircraft deliveries and upgraded traffic expectations. Management expects reasonable net profit growth with strengthening competitive positioning. The fund follows a value-oriented approach, buying more of poorly performing investments as they decline. The managers acknowledge the value investor's curse of buying too early and selling too early, citing examples of premature exits from gold miners and semiconductor companies.		View
2025 Q4	Jan 18, 2026	Dodge & Cox Stock Fund	2.5%	13.7%	AON, AVTR, BAC, BK, BN, CHTR, CMCSA, CVS, FDX, FI, GILD, GOOGL, GSK, JCI, MET, MSFT, OXY, REGN, RTX, SCHW, TSM, WFC, WTW	contrarian, financials, industrials, technology, valuation, value	The fund maintains its value-oriented investment approach despite a fully valued U.S. equity market. The portfolio trades at an attractive valuation of 14.6 times forward earnings, representing a significant discount to the S&P 500 at 22.9 times. The fund continues to find opportunities where long-term fundamentals are not fully reflected in current prices. The fund reduced its overall weighting in the Financials sector while shifting exposure across industries. They trimmed more cyclical bank holdings like Wells Fargo and Bank of America, while increasing exposure to insurance brokers and alternative asset managers. Despite headwinds, they added to Fiserv as its valuation compressed significantly.	FISV	View
2025 Q4	Jan 15, 2026	ClearBridge Investment Value Strategy	0.0%	0.0%	300750.SZ, ARGX, CELH, CHTR, CMA, CORT, FCX, FI, FITB, GPN, ICE, META, MTB, MU, NEM, OM, PYPL, SLGN, TLN, WBS	AI, financials, gold, healthcare, materials, semiconductors, technology, value	AI adoption is expected to broaden economic benefits in 2026, requiring justification of massive capital investment. The team sees opportunities in AI adoption across sectors where it's not currently priced, while maintaining exposure to AI-related infrastructure investments despite reducing exposure during volatility spikes. Value spreads remain at historic extremes with value stocks trading at the cheapest 10% of their history relative to growth. The team believes this creates a probability gap with meaningful upside potential for valuation-driven investors as the market prices value stocks as having little chance of leading. Memory chip demand driven by AI exceeded supply growth, creating price spikes that benefited holdings like Micron Technology. The team correctly anticipated AI would drive memory demand well above supply growth, positioning in picks-and-shovels AI infrastructure plays. Gold prices spiked higher than reflected in mining stock prices, benefiting Newmont Mining. The team has been long-term bullish on gold due to limited annual supply and new demand sources, creating opportunities to buy high-probability events at low-probability prices.	PYPL FITB	View
2025 Q4	Jan 13, 2026	Oakmark Global Select Fund	2.9%	20.7%	BABA, BAYRY, CHTR, CNHI, GOOGL, IQV, MBG.DE, RHHBY, SNY	China, Europe, global, healthcare, Pharmaceuticals, technology, value	The fund is positioned in pharmaceutical companies with strong fundamentals and growth potential. Bayer benefited from positive drug trial results and potential Supreme Court review of litigation matters. Sanofi was added as a new position, featuring the blockbuster drug Dupixent and strong R&D pipeline despite being weighed down by vaccine market volatility and patent cliff concerns. The fund maintains exposure to Chinese e-commerce through Alibaba despite near-term headwinds. While the core e-commerce business performs well and cloud revenue growth accelerates, the company faces earnings pressure from Quick Commerce subsidies. The managers believe losses will reduce over time and see long-term positioning in Chinese AI as valuable.	SAN FP BABA BAYN GR	View
2025 Q4	Jan 13, 2026	Oakmark Select Fund	8.4%	14.3%	CHTR, EFX, GLIBA, GOOGL, IQV, LBRDK, NFLX, PAYC, TRGP, WBD	large cap, M&A, Media, Midstream, undervalued, value	Warner Bros Discovery was the top contributor as multiple parties submitted acquisition offers, with Netflix acquiring the Streaming and Studios business while Global Networks spins to shareholders. Paramount Skydance made a $30 per share offer for the entire company, creating a bidding war that unlocked shareholder value. Targa Resources represents a leading midstream natural gas and NGL company controlling 90% of fractionation capacity at Mont Belvieu hub. The company benefits from cost advantages, barriers to entry, and generates 90% of earnings through multi-year fee-based arrangements providing protection against oversupply. The fund continues to find attractive opportunities to invest in undervalued companies across various industries, including areas left behind in the momentum rally. Targa was purchased at a discount to peers based on normalized earnings power and intrinsic value estimates.	TRGP PAYC WBD	View
2025 Q4	Jan 13, 2026	Oakmark Global Fund	5.2%	21.2%	005930.KS, BABA, CHTR, CNHI, DSV.CO, GM, IQV, IT, MBG.DE, MDLZ	consumer, global, healthcare, Performance, semiconductors, technology, value	Samsung Electronics was the top contributor as earnings staged a sharp recovery due to strength in its core semiconductor business. The company's High Bandwidth Memory product lineup has continued to improve under new management, positioning Samsung as one of the world's leading semiconductor companies with a long runway for future growth. Alibaba Group was the top detractor despite its core E-commerce business continuing to perform well and Cloud revenue growth accelerating. The company was negatively impacted by significant spending on subsidies to grow their Quick Commerce business, though losses are expected to be reduced over time. Mondelez International is a global snacking powerhouse with leading market share positions in crackers, cookies and chocolate. The company possesses a unique global footprint that over-indexes to snacking occasions, benefiting from robust pricing power, low private label competition and rising per capita consumption.	MDLZ IT BABA 005930 KS	View
2022 Q4	Jan 1, 2023	Kovitz Core Equity Strategy	5.3%	-22.6%	AMZN, CHTR, KMX, LOW, LVS, MSI	-			View
2023 Q4	Sep 3, 2024	Concentrated Compounding	0.0%	0.0%	AMZN, BRK/A, CHTR, CSU CN, FRCB, GOOG, TDG	-			View
2023 Q3	Aug 11, 2023	Weitz Large Cap Equity Fund	7.8%	13.3%	CHTR, EFX, MCHP	-			View
2024 Q2	Jul 31, 2024	FPA Crescent Fund	3.7%	12.8%	C, CHTR, KMX	-			View
2024 Q2	Jul 28, 2024	Weitz Multi Cap Equity Fund	10.4%	16.3%	BRK/B, CHTR, CSGP, LSXMK, ODFL	-			View
2023 Q2	Jul 20, 2023	Weitz Value Fund	12.3%	19.0%	AMZN, CHTR, META, VMC	-			View
2024 Q2	Jun 30, 2024	ClearBridge Investments Large Cap Value	0.0%	0.0%	APD, BAC, CHTR, CVS, MCK	-			View
2024 Q1	May 4, 2024	Harris Associates Concentrated Strategy	6.7%	6.7%	CHTR, COF, DE, DIS, KKR, LAD, PSX	-			View
2023 Q1	Apr 13, 2023	Atai Capital Management	6.5%	4.4%	ALOT, ATVI, CABO, CHTR, CMCSA	-			View
2024 Q4	Jan 31, 2025	Alluvium Global Fund	-	-	CHTR, CPRI, DKS, GOOG, GPI, HCA, HRB, LBRDA, LMT, LYB, MA, MCK, RYAAY, V	-			View
2024 Q4	Jan 26, 2025	Brennan Asset Management	-	-	ARCO, CABP LN, CHTR, CODI, LILAK, MEGACPO MM, PTSB LN, TIGO	-			View
2024 Q4	Jan 24, 2025	Sequoia Fund	-0.1%	19.8%	CHTR, ICLR, KMX, LMN CN, RR/ LN, SAP GR, TSM, UMG NA	-			View

Pitches With This Ticker

Date	Pitch Type	Author	Company	Industry	Sub Industry	Bull / Bear	Stock Exchange	Keywords	Action
Jan 31, 2026	Fund Letters	Wally Weitz	Charter Communications Inc.	Communication Services	Cable & Satellite	Bull	New York Stock Exchange	broadband, buybacks, CapEx cycle, Connectivity, Free Cash Flow	View Pitch
Jan 31, 2026	Fund Letters	Wally Weitz	Charter Communications Inc.	Communication Services	Cable & Satellite	Bull	New York Stock Exchange	broadband, buybacks, CapEx cycle, Free Cash Flow	View Pitch
Jan 27, 2026	Fund Letters	Stuart Pearce	Charter Communications, Inc.	Communication Services	Cable & Satellite	Bull	NASDAQ	broadband, CapEx, contrarian, Free cashflow, infrastructure	View Pitch
Oct 6, 2025	Value Investors Club	LiveLaughLove	Charter Communications Inc	Communication Services	Cable & Satellite	—	NASDAQ	Broadband, Cable, FCF, Telecom, Fiber, Wireless	View Pitch

BSD Shareholders of CHTR

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025

Manager Name	Fund Name	Fund AUM	Invested Value	Portfolio Weight	Shares Owned	Shares Bought / Sold During Quarter	% Bought / Sold During Quarter	% of Shares Outstanding Owned
No investor data available.

Join for free and get access to the buyside

Get insights from the world's most influential hedge fund investors direct to your inbox

Follow Us On: